Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1392-1395

  Klepser, Michael E ^a   Wolfe, Erika J ^a   Jones, Ronald N ^b   Nightingale, Charles H ^c,d   Pfaller, Michael A ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c HARTFORD HOSPITAL   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ARTICLE; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

EID: 0030950680     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1392     Document Type: Article

References (8)

1. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jones, T. Horan, et al. 1991. Secular trends in nosocomial primary blood stream infections in the United States, 1980-1989. Arn. J. Med. 91(Suppl. 3B):86S-89S.
2. 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob. Agents Chemother. 37:1270-1277.
3. Klepser, M. E., E. J. Wolfe, and M. A. Pfaller. 1996. Characterization of the fungicidal dynamics of fluconazole (FLU) and amphotericin B (AB) against Cryptococcus neoformans via kill-curve methodologies, abstr. 77, p. 50. In Program and Abstracts of the 34th Annual Meeting of the Infectious Diseases Society of America.
4. Klepser, M. E., E. J. Wolfe, R. N. Jones, C. H. Nightingale, and M. A. Pfaller. 1996. Characterization of the fungicidal dynamics of fluconazole (FLU) and amphotericin B (AB) against C. albicans via kill-curve methodologies, abstr. E51. p. 90. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard M27-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
6. Pearson, R. D., R. T. Steigbigel, H. T. Davis, and S. W. Chapman. 1980. Method for reliable determination of minimum lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18:699-708.
7. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, et al. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo vorrelation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
8. Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb. 1995. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 39:40-44.